Finance

Lists
533573:BOM
Alembic Pharmaceuticals Ltd
791,00 INR
-0,16%
(-1,30) 1D
15 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 533573...
Open
793,00 INR
High
801,90 INR
Low
789,15 INR
Mkt. cap
155,40 მლრ.
Avg. vol.
21,78 ათ.
Volume
8,19 ათ.
Dividend
1,52%
Quarterly dividend
3,00 INR
Ex-dividend date
29 ივლ. 2026
P/E ratio
22,43
52-wk high
998,00 INR
52-wk low
635,30 INR
EPS
35,27 INR
Shares outstanding
188,50 მლნ.
No. of employees
17 ათ.
Open
793,00 INR
High
801,90 INR
Low
789,15 INR
Mkt. cap
155,40 მლრ.
Avg. vol.
21,78 ათ.
Volume
8,19 ათ.
Dividend
1,52%
Quarterly dividend
3,00 INR
Ex-dividend date
29 ივლ. 2026
P/E ratio
22,43
52-wk high
998,00 INR
52-wk low
635,30 INR
EPS
35,27 INR
Shares outstanding
188,50 მლნ.
No. of employees
17 ათ.
News stories
From web sources and news partners
About Alembic Pharmaceuticals Ltd
CEO-
Employees17,2 ათ.
Founded1907
Headquarters-
SectorPharmaceutical industry
Website-
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
19,10 მლრდ.
18,76 მლრდ.
18,48 მლრდ.
21,50 მლრდ.
Cost of goods sold
5,16 მლრდ.
5,29 მლრდ.
6,27 მლრდ.
6,20 მლრდ.
Cost of revenue
5,16 მლრდ.
5,29 მლრდ.
6,27 მლრდ.
6,20 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,38 მლრდ.
4,33 მლრდ.
4,39 მლრდ.
4,74 მლრდ.
Operating expense
11,55 მლრდ.
11,34 მლრდ.
10,85 მლრდ.
12,96 მლრდ.
Total operating expenses
16,71 მლრდ.
16,63 მლრდ.
17,11 მლრდ.
19,16 მლრდ.
Operating income
2,40 მლრდ.
2,13 მლრდ.
1,36 მლრდ.
2,34 მლრდ.
Other non operating income
69,00 მლნ.
154,90 მლნ.
-285,60 მლნ.
149,30 მლნ.
EBT including unusual items
2,24 მლრდ.
1,61 მლრდ.
1,19 მლრდ.
2,22 მლრდ.
EBT excluding unusual items
2,24 მლრდ.
2,04 მლრდ.
1,37 მლრდ.
2,22 მლრდ.
Income tax expense
400,00 მლნ.
295,40 მლნ.
-829,00 მლნ.
495,00 მლნ.
Effective tax rate
17,88%
18,29%
-69,88%
22,31%
Other operating expenses
6,41 მლრდ.
6,21 მლრდ.
5,56 მლრდ.
7,24 მლრდ.
Net income
1,85 მლრდ.
1,33 მლრდ.
2,03 მლრდ.
1,73 მლრდ.
Net profit margin
9,67%
7,09%
10,97%
8,05%
Earnings per share
9,40
8,51
11,57
8,80
Interest and investment income
-
-
8,60 მლნ.
-
Interest expense
-242,30 მლნ.
-233,10 მლნ.
-225,60 მლნ.
-276,10 მლნ.
Net interest expenses
-242,30 მლნ.
-233,10 მლნ.
-217,00 მლნ.
-276,10 მლნ.
Depreciation and amortization charges
760,70 მლნ.
801,20 მლნ.
885,90 მლნ.
977,10 მლნ.
EBITDA
3,15 მლრდ.
2,78 მლრდ.
2,12 მლრდ.
3,09 მლრდ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები